Coherus Oncology, Inc. (CHRS) vs Whitehawk Therapeutics, Inc. (WHWK)
- Coherus Oncology, Inc. CHRS 1.00 −6.54%
- Whitehawk Therapeutics, Inc. WHWK 2.90 −4.61%
Coherus Oncology, Inc. and Whitehawk Therapeutics, Inc. are both Biotechnology companies. Coherus Oncology, Inc. and Whitehawk Therapeutics, Inc. are of similar size ($173.3M and $165.3M). Coherus Oncology, Inc. grew revenue faster over the last twelve months: 61.0% against 16.5%. Whitehawk Therapeutics, Inc. has the higher net margin (0.00% vs −259.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 18 metrics below, Whitehawk Therapeutics, Inc. leads on 12 and Coherus Oncology, Inc. on 6.
Valuation
Profitability
| Metric | CHRS | WHWK | Biotechnology median |
|---|---|---|---|
| Gross margin | 68.94% | 88.72% | 65.16% |
| Operating margin | (311.56%) | 0.00% | 0.00% |
| Net margin | (259.41%) | 0.00% | 0.00% |
| Free cash flow margin | (365.22%) | 0.00% | 0.00% |
| Return on equity | (146.27%) | (44.98%) | (56.36%) |
| Return on assets | (41.90%) | (42.60%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack